Related Experiment Video
Updated: Jul 5, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Chronic headache and pituitary tumors
Miles J Levy1, Manjit Matharu, Peter J Goadsby
1Victoria Building, Leicester Royal Infirmary, LE1 5WW, Leicester, UK. miles.j.levy@uhl-tr.nhs.uk
Current Pain and Headache Reports
|April 18, 2008
Summary
Pituitary tumors can cause headaches through various mechanisms, including local structure distortion and hormonal imbalances. Some headaches may improve with treatments like somatostatin analogues, particularly for hormone-secreting tumors.
Area of Science:
- Neuroendocrinology
- Headache Medicine
- Oncology
Background:
- Pituitary tumors manifest via endocrine issues, local structural compression, or incidental findings.
- Headaches are linked to dura mater stretching and cavernous sinus invasion.
- Small functional pituitary lesions can cause severe headaches without local invasion.
Purpose of the Study:
- To summarize clinical features, pathophysiology, and treatments for pituitary tumor-associated headaches.
- To explore the role of biochemical abnormalities in headache phenotypes.
- To review the efficacy of somatostatin analogues in managing these headaches.
Main Methods:
- Literature review of clinical features and pathophysiology.
- Analysis of headache phenotypes associated with specific pituitary tumor types (e.g., prolactinomas, growth hormone-secreting tumors).
- Evaluation of treatment outcomes, particularly with somatostatin analogues.
Main Results:
- Headaches arise from local compression and potential biochemical factors.
- Prolactinomas and GH-secreting tumors exhibit unique headache patterns.
- Somatostatin analogues show promise in treating headaches linked to active pituitary lesions, possibly via nociceptive peptide inhibition.
Conclusions:
- Pituitary tumor headaches have diverse etiologies, including hormonal influences.
- Specific tumor types correlate with distinct headache characteristics.
- Targeted therapies like somatostatin analogues offer potential relief for certain pituitary tumor-associated headaches.
Related Concept Videos
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:25Chronic Pancreatitis I: Introduction
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
01:24Chronic Pancreatitis I: Introduction
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...